Advertisement

Product › Details
Rydapt®
![]() |
Next higher product group | midostaurin |
![]() |
Status | 2017-10-20 registration start |
![]() |
Organisation | Novartis AG (NYSE: NVS) |
Group | Novartis (Group) | |
Record changed: 2023-07-10 |
Advertisement

More documents for cancer drug_o
- [1] Bayer AG. (7/17/24). "Press Release: Darolutamide Meets Primary Endpoint in Phase III ARANOTE Trial in Men with Metastatic Hormone-sensitive Prostate Cancer [Not intended for U.S. and UK Media]". Berlin....
- [2] Hookipa Pharma Inc.. (1/29/24). "Press Release: Hookipa Pharma Provides Update on Business Priorities and Oncology Partnership Programs". New York, NY & Vienna....
- [3] Merck KGaA. (12/4/23). "Press Release: Merck Strengthens Oncology Portfolio through Commercialization Agreement With Abbisko for Phase III Asset, Pimicotinib [Not intended for UK-, US- or Canada-based media]". Darmstadt....
- [4] Medigene AG. (11/21/23). "Press Release: Medigene AG Announces Prioritization of Pipeline and Resource Allocation as Well as Extension of Cash Runway". Planegg....
- [5] Boundless Bio, Inc.. (5/16/23). "Press Release: Boundless Bio Announces $100 Million Oversubscribed Series C Financing Co-led by Leaps by Bayer and RA Capital Management". San Diego, CA....
- [6] Pieris Pharmaceuticals, Inc.. (4/17/23). "Press Release: Pieris Pharmaceuticals Announces Presentation of Positive Clinical Data for Cinrebafusp Alpa (PRS-343) At 2023 AACR Annual Meeting". Boston, MA....
- [7] Tolremo Therapeutics AG. (6/22/22). "Press Release: Tolremo Therapeutics AG Announces Appointment of Dr. Karl Schumacher as Chief Medical Officer". Muttenz....
- [8] Merck KGaA. (12/20/21). "Press Release: Merck Expands Neuroinflammatory Pipeline with Acquisition of Chord Therapeutics [ Not intended for UK and US based media ]". Darmstadt....
- [9] Diaccurate S.A.. (9/8/21). "Press Release: Diaccurate Acquires Clinical Stage Sole-in-Class Targeted Cancer Therapy from Merck KGaA, Darmstadt, Germany". Paris....
- [10] MorphoSys AG. (8/26/21). "Press Release: MorphoSys and Incyte Announce the European Commission Approval of Minjuvi (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma". Plan...
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top